The relevance of the public-private partnership paradigm to the prevention of diet-associated non-communicable diseases in wealthy countries

Global Public Health
Michael A Stevenson

Abstract

The public-private partnership (PPP) paradigm emerged as a form of global health governance in the mid-1990s to overcome state and market failures constraining access to essential medicines among populations with limited purchasing power in low- and middle-income countries. PPPs are now ubiquitous across the development spectrum. Yet while the narrative that the private sector must be engaged if complex health challenges are to be overcome is now dominant in development discourse, it does not yet appear to be shaping government approaches to addressing health inequalities within high-income welfare states such as Canada. This is significant as both the actions and inactions of firms factor heavily into why low-income Canadians face a disproportionate risk of developing diet-associated chronic diseases, such as type II diabetes. In the same ways PPPs have been an effective policy tool for strengthening public health in poor countries, this paper illuminates how the PPP model may have utility for mitigating poverty-associated food insecurity giving rise to diet-associated non-communicable diseases within the context of wealthy states.

References

Mar 6, 1999·Vaccine·R T Mahoney, J E Maynard
Jan 5, 2000·Social Science & Medicine·J A de BeyerR G Feachem
Sep 21, 2006·Health Policy and Planning·Jeremy Shiffman
Oct 24, 2006·Social Science & Medicine·Kent Buse, Andrew M Harmer
Nov 23, 2007·Nature·Abdallah S DaarJohn Bell
Dec 13, 2007·The Medical Journal of Australia·Derek YachCarlos Barroso
Feb 14, 2008·European Journal of Clinical Nutrition·C L Fischer WalkerR E Black
Feb 26, 2008·Public Health Nutrition·Derek Yach
Jul 9, 2008·International Journal of Obesity : Journal of the International Association for the Study of Obesity·T KellyJ He
Sep 4, 2008·Sociology of Health & Illness·Clare Herrick
Apr 17, 2009·Nursing for Women's Health·Margot R De Sevo
Jan 27, 2010·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Grace M EgelandIsaac Sobol
Mar 20, 2010·Nature·Declan Butler
Jun 1, 2010·Globalization and Health·Derek YachGeorge Mensah
Aug 21, 2010·Health Policy·Serban Dinca-PanaitescuDennis Raphael
Oct 1, 2010·The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics·Roger S Magnusson
Apr 9, 2011·Lancet·Robert BeagleholeUNKNOWN NCD Alliance
Nov 15, 2011·Diabetes Research and Clinical Practice·David R WhitingJonathan Shaw
Mar 8, 2012·Future Medicinal Chemistry·Leyte L Winfield, Florastina Payton-Stewart
Jun 23, 2012·PLoS Medicine·David Stuckler, Marion Nestle
Jul 19, 2012·Bulletin of the World Health Organization·Lizell B MadsenFlemming Konradsen
Apr 19, 2013·BMJ : British Medical Journal·Derek Yach
Apr 19, 2013·BMJ : British Medical Journal·Klim McPherson
Jan 8, 2014·Globalization and Health·Arne Ruckert, Ronald Labonté
Feb 4, 2014·The Medical Journal of Australia·Tamara ElliottBruce C Neal
Apr 2, 2014·International Journal of Health Services : Planning, Administration, Evaluation·Alex Scott-SamuelKat Smith

❮ Previous
Next ❯

Software Mentioned

GAVI
GAIN

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.